FDA Inspection 1022661 — Alembic Pharmaceuticals Limited
The FDA completed an inspection of Alembic Pharmaceuticals Limited on Apr 12, 2017 in Vadodara. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 12, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Vadodara (India)
Additional Details
Postmarket Adverse Drug Experience (PADE)